Aspirin responsive platelet thrombophilia in essential thrombocythemia and polycythemia vera

doi:10.5315/wjh.v2.i2.20

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15679)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-11) series, Tables (1-9) series.

Item

Count

PDF

650

HTML

11442

Figures (1-11)

292

Tables (1-9)

259

Sum=12643

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1918

Download

1117

Sum=3035

May 6, 2013 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Hematol. May 6, 2013; 2(2): 20-43
Published online May 6, 2013. doi: 10.5315/wjh.v2.i2.20

Full Size Figure Download Figure

Figure 2 β-thromboglobuline levels in healthy control, and in essential thrombocythemia (E) either asymptomatic (E-), complicated by erythromelalgia (E+) and after treatment of E+ with aspirin (E+ → E-)[24]. ^bP < 0.01, significant differences between E- and E+ > E- as compared to E+.

Citation: Michiels JJ, Ten Kate FW, Koudstaal PJ, Van Genderen PJ. Aspirin responsive platelet thrombophilia in essential thrombocythemia and polycythemia vera. World J Hematol 2013; 2(2): 20-43
URL: https://www.wjgnet.com/2218-6204/full/v2/i2/20.htm
DOI: https://dx.doi.org/10.5315/wjh.v2.i2.20